9207791 |
Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3
Kuehl, WM,
Nardini, E,
Chesi, M,
Brents, LA,
Schröck, E,
Bergsagel, PL,
Ried, T
|
Nat Genet |
1997 |
10568829 |
Expression of fibroblast growth factor and FGF-receptor family genes in human myeloma cells, including lines possessing t(4;14)(q16.3;q32. 3) and FGFR3 translocation
Otsuki, T,
Kurebayashi, J,
Ueki, A,
Sakaguchi, H,
Taniwaki, M,
Yamada, O,
Yata, K,
Nakazawa, N,
Yawata, Y
|
Int J Oncol |
1999 |
19381019 |
Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice
Stephan, JP,
Dornan, D,
Stinson, S,
Wiesmann, C,
Du, X,
Wu, P,
Qing, J,
Ashkenazi, A,
Wu, Y,
Tien, J,
French, D,
Totpal, K,
Chan, P,
Chen, Y,
Marsters, S,
Ross, S,
Li, H,
Wang, QR,
Stawicki, S
|
J Clin Invest |
2009 |
11290605 |
The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells
Hawley, TS,
Patterson, B,
Chesi, M,
Plowright, EE,
Stewart, AK,
Bergsagel, PL,
Zhu, YX,
Hawley, RG,
Li, Z
|
Blood |
2001 |
11429702 |
Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations
Otsuki, T,
Lombardi, L,
Colombo, G,
Greco, A,
Compasso, S,
Neri, A,
Ronchetti, D,
Dell'Era, P
|
Oncogene |
2001 |
9865713 |
High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies
Harousseau, JL,
Talmant, P,
Li, JY,
Avet-Loiseau, H,
Jaccard, A,
Facon, T,
Bataille, R,
Rapp, MJ,
Morineau, N,
Trimoreau, F,
Maloisel, F,
Brigaudeau, C
|
Cancer Res |
1998 |
11157491 |
Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma
Mesri, EA,
Kuehl, WM,
Ely, SA,
Chesi, M,
Brents, LA,
Bergsagel, PL,
Bais, C,
Robbiani, DF
|
Blood |
2001 |